John Hill

Senior Vice President

John Hill is an accomplished senior executive with extensive experience in the pharmaceutical and biotechnology industries. As the Senior Vice President at Biosplice Therapeutics, he leverages his deep expertise in drug discovery, clinical research, and asset management to drive the company's strategic initiatives.

Professional Overview

With over 35 years of industry experience, John has established himself as a respected leader in the fields of oncology and translational medicine. He possesses a unique blend of scientific acumen, strategic thinking, and operational excellence, which he applies to deliver impactful results for his organizations.

Current Role

As the Senior Vice President at Biosplice Therapeutics, John is responsible for overseeing the company's discovery research efforts and managing its growing portfolio of innovative therapeutics. He collaborates closely with cross-functional teams to identify and advance promising drug candidates, ensuring alignment with the company's long-term objectives. Under his leadership, Biosplice has made significant strides in the development of novel treatments, positioning the company as a key player in the industry.

Career Progression

Prior to his current role, John held several senior positions at Pfizer and Pharmacyclics (an AbbVie company), where he demonstrated his ability to drive strategic initiatives and deliver tangible results. As the Vice President at Pfizer, he led the early oncology development and clinical research efforts, contributing to the advancement of the company's pipeline. At Pharmacyclics, he served as the Senior Director, Leader of Translational Medicine Department, and Senior Director, Clinical Science, playing a pivotal role in the development of Imbruvica, a groundbreaking treatment for hematological malignancies.

Academic Background

John holds a Ph.D. in Neurosurgery/Neuro-oncology Cell Biology from The Royal Melbourne Hospital, where he conducted pioneering research in the field of brain cancer. His academic achievements and specialized training have equipped him with a deep understanding of the scientific principles underlying drug development and clinical research.

Areas of Expertise

• Drug discovery and development

• Oncology and hematological malignancies

• Translational medicine and biomarker research

• Clinical trial design and execution

• Cross-functional team leadership and collaboration

• Strategic portfolio management and asset optimization

Professional Impact

Throughout his career, John has made significant contributions to the advancement of novel therapies and the improvement of patient outcomes. His work has been recognized through numerous publications in peer-reviewed journals and presentations at industry conferences. As a respected thought leader, he actively engages with the scientific community, sharing his expertise and insights to drive innovation in the pharmaceutical and biotechnology sectors.

Conclusion

With his exceptional track record, John Hill is poised to continue driving Biosplice Therapeutics' success as the Senior Vice President. His deep industry knowledge, scientific acumen, and strategic leadership make him a valuable asset in the company's pursuit of advancing transformative therapies for patients in need.